Prof. Rui Ma 马锐
Chief Physician, Professor
Internal Medicine, Liaoning Cancer Hospital & Institute, Shenyang
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis, chemotherapy, and targeted therapy for lung cancer, lymphoma, breast cancer, liver cancer, and gastrointestinal malignancies. Management of tumor emergencies and complications.
Dr. Ma is Director of the Second Thoracic Internal Medicine Department at Liaoning Cancer Hospital & Institute. Dr. Ma holds a PhD in Oncology from China Medical University (2005). With over 20 years of experience, Dr. Ma focuses on individualized medical treatment for lung, breast, digestive tract, and elderly tumors, including neoadjuvant and adjuvant chemotherapy, targeted therapy, and biological therapy.
Professional roles
- Chair, Tumor Metastasis Professional Committee, Liaoning Anti-Cancer Association
- Chair, Lung Cancer Professional Committee, Liaoning Life Science Society
- Vice Chair, 8th Internal Medicine Branch, Liaoning Medical Association
- Member, Tumor Metastasis Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Ma Rui). Papers usually list the name as Rui Ma or Ma R.
Selected publications
42 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Neoplasma, 2024 (senior author): Silencing of lncRNA LOC105376794 promotes migration, invasion, and Gefitinib resistance of lung adenocarcinoma cells with EGFR 19Del mutation by ATF4/CHOP axis and ERK phosphorylation. PubMed 38958710
- Heliyon, 2023 (senior author): N-telopeptide as a potential diagnostic and prognostic marker for bone metastasis in human cancers: A meta-analysis. PubMed 37215848
- Int J Biol Markers, 2022 (senior author): Diagnostic and prognostic value of microRNA-486 in patients with lung cancer: A systematic review and meta-analysis. PubMed 35902998
- Biomed Res Int, 2021 (senior author): lncRNA OXCT1-AS1 Promotes Metastasis in Non-Small-Cell Lung Cancer by Stabilizing LEF1, In Vitro and In Vivo. PubMed 34337014
- Cancer Manag Res, 2021 (senior author): Plakophilin-2 Promotes Lung Adenocarcinoma Development via Enhancing Focal Adhesion and Epithelial-Mesenchymal Transition. PubMed 33519235
- Int J Clin Exp Med, 2015 (senior author): Association of 8q23-24 region (8q23.3 loci and 8q24.21 loci) with susceptibility to colorectal cancer: a systematic and updated meta-analysis. PubMed 26885031
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion